<html xmlns="http://www.w3.org/1999/xhtml"> <head> <style type="text/css">
      	     		 
      	    a                          {background : #ffffff; }
      	    article                    {border-style : dotted; border-width : 2px; }
		 	
		 	div                        {background : #ffffcc;}
		 	div.abstract-title         {font-weight : bold ; font-size : 16pt;}
		 	div.ack                    {border-style : solid ; border-color : red; margin : 2em; }
		 	div.article-meta           {border-style : solid; border-width : 1 pt; margin 1em;}
		 	div.boxed-text             {margin : 5em; border-style : solid;}
		 	div.contrib-group          {margin : 1em; }
		 	div.fig                    {border-style : solid; border-width : 2px; margin : 2em; }
		 	div.funding                {font-weight : bold ; font-size : 16pt;}
		 	div.given-names            {font-style : italic;}
		 	div.intro                  {border-style : inset; margin : 5px;}
		 	div.introduction           {border-style : inset; margin : 5px;}
		 	div.journal-meta           {border-style : solid; border-width : 1 pt; margin 1em;}
		 	div.journal-title-group    {background : #ffeeee;}
		 	div.article-title          {font-weight : bold ; font-size : 18pt;}
		 	div.kwd                    {font-style : italic}
		 	div.meta-name              {font-weight : bold ; font-size : 16pt;}
		 	div.name                   {font-weight : bold;}
		 	div.alt-title              {font-style : italic; font-size : 12px;}
		 	
		 	div.sec                    {border : 2px; margin 5px; padding 2px;}
		 	div.title                  {font-family : courier; font-weight : bold;
		 	                            font-size : 16pt; margin : 5px;}
		 	
		 	div.materials_methods      {border-style : double; margin : 5px; }
		 	div.methods                {border-style : double; margin : 5px; }
		 	
		 	div.results                {border-style : solid; margin : 5px;}
		 	div.background             {border-style : dotted; margin : 5px;}
		 	
		 	div.discussion             {border-style : groove; margin : 5px;}
		 	div.conclusion             {border-style : ridge; margin : 5px;}
		 	div.conclusions             {border-style : ridge; margin : 5px;}
		 	div.supplementary-material {border-style : inset; margin : 5px;}
		 	div.abbreviations          {border-style : double; border-color : red; margin : 5px;}
		 	div.competinginterests     {border-style : double; border-color : blue; margin : 5px;}
		 	div.acknowledgements       {border-style : double; border-color : green; margin : 5px;}
		 	div.authors_contributions   {border-style : double; border-color : purple; margin : 5px;}
		 	
		 	div.publisher              {border-style : outset; margin : 5px;}
		 	div.fn-type-conflict       {background : #f88; }
		 	div.fn-type-con            {background : #ddf; }
		 	div.fn-type-other          {background : #ddd; }
		 	
		 	div.unknown                {background : #ffd;
									 	  border-style : solid;
									 	  border-width : 1px;
									 	  padding : 2 px;}
		 	  
      	    table                      {background : #ffffdd;}
		 	tr                         {background : #ddddff; padding : 1px;}
		 	
		 	span                       {background : #ffcccc;}
		 	
		 	span.citation-author       {font-family : helvetica; background : #ffeeee;}
		 	span.collab                {background : #ddffff; }
		 	span.comment               {font-family : courier; font-size : 6px; background : #ffaaff;}
		 	span.contrib               {background : #ffffff;}
		 	span.corresp               {background : #ddffdd; }
		 	span.doi                   {background : #ffffff;}
		 	span.email                 {font-family : courier; }
		 	span.etal                  {font-style : italic;}
		 	span.fpage                 {font-family : courier;}
		 	span.given-names           {background : #ffffff;}
		 	span.iso-abbrev            {background : #ffffff;}
		 	span.issn-epub             {background : #ffffff;}
		 	span.issn-ppub             {background : #ffffff;}
		 	span.journal-title         {background : #ffffff;}
		 	span.lpage                 {font-family : courier;}
		 	span.mixed-article-title   {font-style : italic ;}
		 	span.nlm-ta                {background : #ffffff;}
		 	span.pmc                   {background : #ffffff;}
		 	span.pmcid                 {background : #ffffff;}
		 	span.pmid                  {background : #ffffff;}
		 	span.publisher             {background : #ffffff;}
		 	span.publisher-id          {background : #ffffff;}
		 	span.publisher-name        {background : #ffffff;}
		 	span.source                {background : #ffffff;}
		 	span.subject               {background : #ffffff;}
		 	span.surname               {background : #ffffff;}
		 	span.volume                {font-family : courier; font-weight : bold;}
		 	span.year                  {font-family : courier ; font-style : italic;}
			</style> </head> <body> <div class="front" title="front"> <div class="journal-meta" tagx="journal-meta" title="journal-meta"><span class="nlm-ta" title="nlm-ta">Neurologia</span><span class="iso-abbrev" title="iso-abbrev">Neurologia</span><div class="journal-title-group" tagx="journal-title-group" title="journal-title-group"><span class="journal-title" tagx="journal-title" title="journal-title">Neurologia (Barcelona, Spain)</span></div><span class="issn-ppub" tagx="issn" title="issn-ppub">0213-4853</span><span class="issn-epub" tagx="issn" title="issn-epub">1578-1968</span><div class="publisher" tagx="publisher" title="publisher"><span class="publisher-name" tagx="publisher-name" title="publisher-name">Sociedad EspaÃ±ola de NeurologÃ­a. Published by Elsevier EspaÃ±a, S.L.U.</span></div> </div> <div class="article-meta" tagx="article-meta" title="article-meta"><span class="pmcid" title="pmcid"> pmcid: <a href="http://www.ncbi.nlm.nih.gov/pubmed/7164900">7164900</a></span><span class="publisher-id" title="publisher-id">S0213-4853(20)30067-0</span><span class="doi" title="doi"> doi: <a href="https://dx.doi.org/10.1016/j.nrl.2020.04.002">10.1016/j.nrl.2020.04.002</a></span><div class="article-categories" title="article-categories">
: <span class="subject" title="subject">Article</span></div> <div class="title-group" tagx="title-group" title="title-group"> <div class="article-title" title="article-title">
Influencia de la infecciÃ³n SARS-CoV-2 sobre enfermedades neurodegenerativas y neuropsiquiÃ¡tricas: Â¿una pandemia demorada?</div><span class="trans-title-group" tagx="trans-title-group" title="trans-title-group"><span class="trans-title" tagx="trans-title" title="trans-title">Impact of SARS-CoV-2 infection on neurodegenerative and neuropsychiatric diseases: a delayed pandemic?</span></span></div> <div class="contrib-group" title="contrib-group"><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Serrano-Castro</span><span class="given-names" tagx="given-names" title="given-names">P.J.</span></span><span class="email" tagx="email" title="email">pedro.serrano.c@gmail.com</span><a href="#aff0005">a</a><a href="#aff0010">b</a><a href="#aff0015">c</a><a href="#fn0005">â—Š</a><a href="#cor0005">â�Ž</a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Estivill-TorrÃºs</span><span class="given-names" tagx="given-names" title="given-names">G.</span></span><a href="#aff0010">b</a><a href="#aff0015">c</a><a href="#fn0005">â—Š</a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Cabezudo-GarcÃ­a</span><span class="given-names" tagx="given-names" title="given-names">P.</span></span><a href="#aff0005">a</a><a href="#aff0010">b</a><a href="#aff0015">c</a><a href="#fn0005">â—Š</a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Reyes-Bueno</span><span class="given-names" tagx="given-names" title="given-names">J.A.</span></span><a href="#aff0005">a</a><a href="#aff0010">b</a><a href="#aff0015">c</a><a href="#fn0005">â—Š</a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ciano Petersen</span><span class="given-names" tagx="given-names" title="given-names">N.</span></span><a href="#aff0005">a</a><a href="#aff0010">b</a><a href="#aff0015">c</a><a href="#fn0005">â—Š</a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Aguilar-Castillo</span><span class="given-names" tagx="given-names" title="given-names">M.J.</span></span><a href="#aff0015">c</a><a href="#aff0020">d</a><a href="#fn0005">â—Š</a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">SuÃ¡rez-PÃ©rez</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span><a href="#aff0010">b</a><a href="#aff0015">c</a><a href="#fn0005">â—Š</a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">JimÃ©nez-HernÃ¡ndez</span><span class="given-names" tagx="given-names" title="given-names">M.D.</span></span><a href="#aff0015">c</a><a href="#aff0025">e</a><a href="#fn0005">â—Š</a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Moya-Molina</span><span class="given-names" tagx="given-names" title="given-names">M.Ã�.</span></span><a href="#aff0015">c</a><a href="#aff0030">f</a><a href="#fn0005">â—Š</a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Oliver-Martos</span><span class="given-names" tagx="given-names" title="given-names">B.</span></span><a href="#aff0010">b</a><a href="#aff0015">c</a><a href="#fn0005">â—Š</a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Arrabal-GÃ³mez</span><span class="given-names" tagx="given-names" title="given-names">C.</span></span><a href="#aff0010">b</a><a href="#aff0015">c</a><a href="#fn0005">â—Š</a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">RodrÃ­guez de Fonseca</span><span class="given-names" tagx="given-names" title="given-names">F.</span></span><a href="#aff0010">b</a><a href="#aff0015">c</a><a href="#fn0005">â—Š</a></span><span class="citation_author_institution" id="aff0005">[a], </span><span class="citation_author_institution" id="aff0010">[b], </span><span class="citation_author_institution" id="aff0015">[c], </span><span class="citation_author_institution" id="aff0020">[d], </span><span class="citation_author_institution" id="aff0025">[e], </span><span class="citation_author_institution" id="aff0030">[f], </span></div> <div class="author-notes" title="author-notes"> <div class="corresp" title="corresp"><span class="label" tagx="label" title="label">â�Ž</span>Autor para correspondencia. <span class="email" tagx="email" title="email">pedro.serrano.c@gmail.com</span></div> <div class="fn-type-" title=""><span class="label" tagx="label" title="label">â—Š</span><p id="npar0005">MÃ¡s informaciÃ³n sobre Neuro-RECA estÃ¡ disponible en el <a href="#sec0020">Anexo</a>.</p> </div> </div><span class="pub-date-pmc-release" title="pub-date-pmc-release">pmc-release: <span>2020-4-4</span></span><span class="pub-date-epub" title="pub-date-epub">epub: <span>2020-4-4</span></span><span class="history" title="history"><span class="received" title="received">received: 2020-4-10</span><span class="accepted" title="accepted">accepted: 2020-4-14</span></span><div class="permissions"><span class="copyright" title="copyright">(C) <span class="copyright-holder" tagx="copyright-holder" title="copyright-holder">Sociedad EspaÃ±ola de NeurologÃ­a</span>, <span class="copyright-year" tagx="copyright-year" title="copyright-year">2020</span></span><span class="license" title="license"><span class="license-p" title="license-p">Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.</span></span></div> <div class="abstract" title="abstract"> <div class="abstract-title" title="abstract-title">
Abstract</div> <div class="title" tagx="title" title="title">
Resumen</div> <div class="introducciÃ³n" title="sec"> <div class="title" tagx="title" title="title">
IntroducciÃ³n</div> <p>La infecciÃ³n por el coronavirus SARS-CoV-2 originada en diciembre de 2019 en la regiÃ³n china de Wuhan ha adquirido proporciones pandÃ©micas. A dÃ­a de hoy ha ocasionado mÃ¡s de 1,7 millones de contagios y mÃ¡s de 100.000 muertes en todo el mundo. La investigaciÃ³n cientÃ­fica actual se centra en el mejor conocimiento de la infecciÃ³n aguda y de sus estrategias terapÃ©uticas. Dada la magnitud de la epidemia, planteamos una revisiÃ³n especulativa sobre las posibles consecuencias en patologÃ­a neurolÃ³gica a medio/largo plazo, con especial atenciÃ³n a enfermedades neurodegenerativas y neuropsiquiÃ¡tricas con base neuroinflamatoria, teniendo en cuenta la evidencia directa de afectaciÃ³n neurolÃ³gica a causa de la infecciÃ³n aguda.</p> </div> <div class="desarrollo" title="sec"> <div class="title" tagx="title" title="title">
Desarrollo</div> <p>Revisamos de forma sistemÃ¡tica lo conocido sobre los mecanismos patogÃ©nicos de la infecciÃ³n por SARS-CoV-2, la repercusiÃ³n de la tormenta de citoquinas sobre el sistema nervioso central y su persistencia en el tiempo y las consecuencias que la neuroinflamaciÃ³n puede tener sobre el sistema nervioso central.</p> </div> <div class="conclusiones" title="sec"> <div class="title" tagx="title" title="title">
Conclusiones</div> <p>El SARS-CoV-2 es un virus neuroinvasivo capaz de provocar una tormenta de citoquinas que podrÃ­a convertirse en persistente en poblaciÃ³n seleccionada. Aunque nuestra hipÃ³tesis tiene alto componente especulativo, la repercusiÃ³n que esta situaciÃ³n puede tener en la puesta en marcha y progresiÃ³n de enfermedades neurodegenerativas y neuropsiquiÃ¡tricas con base neuroinflamatoria debe ser considerada como posible germen de una pandemia demorada que podrÃ­a tener un gran impacto en salud pÃºblica a medio o largo plazo. Se hace necesario un estrecho seguimiento de la salud cognitiva y neuropsiquiÃ¡trica de los pacientes supervivientes a infecciÃ³n COVID-19.</p> </div> </div><span class="trans-abstract" tagx="trans-abstract" title="trans-abstract"> <div class="introduction" title="sec"> <div class="title" tagx="title" title="title">
Introduction</div> <p>SARS-CoV-2 was first detected in December 2019 in the Chinese city of Wuhan and has since spread across the world. At present, the virus has infected over 1.7 million people and caused over 100 000 deaths worldwide. Research is currently focused on understanding the acute infection and developing effective treatment strategies. In view of the magnitude of the epidemic, we conducted a speculative review of possible medium- and long-term neurological consequences of SARS-CoV-2 infection, with particular emphasis on neurodegenerative and neuropsychiatric diseases of neuroinflammatory origin, based on the available evidence on neurological symptoms of acute SARS-CoV-2 infection.</p> </div> <div class="development" title="sec"> <div class="title" tagx="title" title="title">
Development</div> <p>We systematically reviewed the available evidence about the pathogenic mechanisms of SARS-CoV-2 infection, the immediate and lasting effects of the cytokine storm on the central nervous system, and the consequences of neuroinflammation for the central nervous system.</p> </div> <div class="conclusions" title="sec"> <div class="title" tagx="title" title="title">
Conclusions</div> <p>SARS-CoV-2 is a neuroinvasive virus capable of triggering a cytokine storm, with persistent effects in specific populations. Although our hypothesis is highly speculative, the impact of SARS-CoV-2 infection on the onset and progression of neurodegenerative and neuropsychiatric diseases of neuroinflammatory origin should be regarded as the potential cause of a delayed pandemic that may have a major public health impact in the medium to long term. Cognitive and neuropsychological function should be closely monitored in COVID-19 survivors.</p> </div></span><div class="kwd-group"> <div class="title" tagx="title" title="title">
Palabras clave</div> <div class="kwd" title="kwd">
COVID-19</div> <div class="kwd" title="kwd">
SARS-CoV-2</div> <div class="kwd" title="kwd">
NeuroinflamaciÃ³n</div> <div class="kwd" title="kwd">
Enfermedades neurodegenerativas</div> <div class="kwd" title="kwd">
Enfermedades neuropsiquiÃ¡tricas</div> <div class="kwd" title="kwd">
Tormenta de citoquinas</div> </div> <div class="kwd-group"> <div class="title" tagx="title" title="title">
Keywords</div> <div class="kwd" title="kwd">
COVID-19</div> <div class="kwd" title="kwd">
SARS-CoV-2</div> <div class="kwd" title="kwd">
Neuroinflammation</div> <div class="kwd" title="kwd">
Neurodegenerative diseases</div> <div class="kwd" title="kwd">
Neuropsychiatric diseases</div> <div class="kwd" title="kwd">
Cytokine storm</div> </div> </div> </div> <div class="body" title="body"> <div class="introducciÃ³n" title="sec"> <div class="title" tagx="title" title="title">
IntroducciÃ³n</div> <p id="par0010">En el mes de diciembre de 2019, un nuevo virus perteneciente a la familia de los coronavirus irrumpiÃ³ como agente patÃ³geno en la regiÃ³n china de Wuhan provocando un sÃ­ndrome respiratorio agudo severo (SARS) de alta letalidad<a href="#bib0210">1</a>, <a href="#bib0215">2</a>, <a href="#bib0220">3</a>. La OrganizaciÃ³n Mundial de la Salud (OMS) le dio el nombre de SARS-CoV-2 dada su similitud desde el punto de vista virolÃ³gico y tambiÃ©n en su expresiÃ³n clÃ­nica con el SARS-CoV-1 (229E [HCoV-229E]), responsable de un sÃ­ndrome de similares caracterÃ­sticas tambiÃ©n originado en los mercados de animales de China en el aÃ±o 2003.</p> <p id="par0015">Dada la expansiÃ³n vertiginosa que se produjo en las semanas siguientes a su primera descripciÃ³n por muchos paÃ­ses del mundo, la propia OMS declarÃ³ a la enfermedad producida por el SARS-CoV-2 como pandemia de alcance mundial el dÃ­a 11 de marzo de 2020. En el momento de redactar este artÃ­culo, ha sido capaz de infectar a mÃ¡s de 1,7 millones de personas en mÃ¡s de 200 paÃ­ses del mundo y acabar con la vida de 100.000 personas, aunque con toda probabilidad ambas cifras estÃ¡n subestimadas<a href="#bib0225"><sup>4</sup></a>. El nombre oficial de esta enfermedad segÃºn la OMS es enfermedad por coronavirus 2019 (COVID-19).</p> <p id="par0020">En general, los coronavirus que afectan a los seres humanos, y cuyo origen y posible reservorio son animales salvajes incluyendo los murciÃ©lagos, pueden ser clasificados en aquellos con baja capacidad patogÃ©nica, que incluyen los HCoV-229E, HCoV-OC43, HCoV-NL63, y HCoV-HKU (coronavirus Î±) y aquellos otros altamente patogÃ©nicos, denominados bajo la categorÃ­a CoV, tales como el SARS-CoV (responsable del brote de SARS de 2003), el actual (SARS-CoV-2), junto con el que produjo el Middle East Respiratory SÃ­ndrome (MERS-CoV) en el aÃ±o 2012. A estos se los denomina tambiÃ©n coronavirus Î².</p> <p id="par0025">Los coronavirus Î² se han convertido en un verdadero problema de salud pÃºblica por su alta patogenicidad e infectividad. Durante la epidemia de 2002-2003 el SARS-CoV infectÃ³ aproximadamente a 8400 personas, con una tasa de mortalidad del 9,6%<a href="#bib0230"><sup>5</sup></a>. El MERS-CoV, por su parte, infectÃ³ a un total de 1936 individuos, dejando un resultado mortal de 690 muertos, lo que equivale a una tasa de mortalidad de aproximadamente el 36%<a href="#bib0235"><sup>6</sup></a>.</p> <p id="par0030">En el caso del SARS-CoV-2, aunque hay formas prÃ¡cticamente asintomÃ¡ticas, tambiÃ©n es cierto que, en grupos de riesgo determinados, puede progresar a sÃ­ndromes severos con alta letalidad cuyas principales manifestaciones clÃ­nicas se producen a nivel respiratorio, con una neumonÃ­a atÃ­pica bilateral con importante afectaciÃ³n de la funciÃ³n respiratoria por daÃ±o alveolar difuso y que constituye su marca patogÃ©nica. Pero el SARS-CoV-2 tambiÃ©n puede infectar otros Ã³rganos y tipos celulares durante el curso de la enfermedad, incluyendo las cÃ©lulas mucosas del intestino, las cÃ©lulas tubulares del riÃ±Ã³n, cÃ©lulas del sistema linfoide y retÃ­culo endotelial y tambiÃ©n las cÃ©lulas del sistema nervioso<a href="#bib0240"><sup>7</sup></a>.</p> <p id="par0035">Precisamente, esa capacidad de afectar al sistema nervioso serÃ¡ objeto de esta revisiÃ³n, centrÃ¡ndonos en la posibilidad de generar afectaciÃ³n en el medio plazo como resultado de la invasiÃ³n neurolÃ³gica y su posible incidencia sobre procesos neurodegenerativos.</p> <p id="par0040"><i>Fases de la expresiÃ³n clÃ­nica de las infecciones por CoV</i></p> <p id="par0045">La expresiÃ³n clÃ­nica de la infecciÃ³n por SARS-CoV (que ha servido de modelo para el SARS-CoV-2 dado que usa mecanismos de infectividad parecidos, incluyendo la enzima convertidora de la angiotensina II [ECA-II] como receptor de internalizaciÃ³n), consta de tres fases. La fase inicial se caracteriza por gran replicaciÃ³n viral, con fiebre, tos y quebrantamiento general que se prolonga durante varios dÃ­as. La segunda fase se asocia con fiebre alta, hipoxemia y progresiÃ³n de la sintomatologÃ­a respiratoria hasta una neumonÃ­a bilateral a pesar de que se aprecia analÃ­ticamente ya un declive en la carga viral al final de esta fase<a href="#bib0245"><sup>8</sup></a>. Durante la tercera fase, aproximadamente un 20% de los pacientes progresan a un SARS, que con frecuencia tiene desenlace fatal<a href="#bib0250">9</a>, <a href="#bib0255">10</a>. Como durante esta fase hay una progresiva caÃ­da de carga viral, la patogenia de esta crisis se cree que es debida a una exacerbada respuesta inflamatoria por parte del huÃ©sped a la que se ha denominado Â«tormenta de citoquinasÂ», y que al generar daÃ±o alveolar difuso e hipoxemia grave, facilita la apariciÃ³n de sepsis secundarias letales.</p> <p id="par0050">Un hecho esencial para comprender la respuesta inflamatoria a las infecciones CoV es comprender el punto de partida. Dado que se trata de agentes patÃ³genos de muy reciente apariciÃ³n, existe una ausencia completa de memoria inmunitaria en la comunidad. Nunca antes el sistema inmunitario del ser humano se ha enfrentado a un coronavirus de este tipo. En situaciones como esta, el sistema inmunolÃ³gico recurre a la denominada inmunidad innata como primera lÃ­nea de defensa. Precisamente es la respuesta inmunolÃ³gica excesiva y desregulada de esta primera lÃ­nea defensiva la que puede ser responsable de una severa inmunopatologÃ­a<a href="#bib0260">11</a>, <a href="#bib0265">12</a>.</p> <p id="par0055">En el caso del SARS-CoV, la invasiÃ³n de cÃ©lulas hematopoyÃ©ticas, tales como cÃ©lulas dendrÃ­ticas, monocitos o macrÃ³fagos induce una expresiÃ³n de bajo nivel de citoquinas antivirales como el IFN-Î±Î² y una sobreexpresiÃ³n de citoquinas proinflamatorias como el factor de necrosis tumoral (TNF) y la interleukina-6 (IL6) y tambiÃ©n de quimioquinas inflamatorias como CCL3, CCL5, CCL2, y CXCL10<a href="#bib0270"><sup>13</sup></a>. Por el contrario, los pacientes con SARS-CoV con enfermedad severa muestran muy bajos niveles de citoquinas antiinflamatorias tales como la IL10<a href="#bib0275"><sup>14</sup></a> y elevados niveles de IFN-Î± y IFN-Î³ asÃ­ como de genes estimuladores del IFN (CXCL10 y CCL-2) en comparaciÃ³n con pacientes con enfermedad leve sugiriendo un posible papel del IFN en la inmunopatogÃ©nesis del SARS en humanos<a href="#bib0275"><sup>14</sup></a>.</p> <p id="par0060">En el momento de redactar este artÃ­culo, existen pocas publicaciones que aborden la dinÃ¡mica de la tormenta de citoquinas en la infecciÃ³n por SARS-CoV-2. Muy recientemente, Chen et al. presentaron un estudio en el que demuestran que la infecciÃ³n por SARS-CoV-2 severa se asocia con linfopenia a expensas de caÃ­das de linfocitos T CD4+ y CD8+ pero no de linfocitos B, hiperproducciÃ³n de citoquinas IL6, IL2R (receptor soluble de la IL2), IL10, TNFÎ± y CCL2 y descenso en la expresiÃ³n de IFN-Î³ en linfocitos T CD4+<a href="#bib0280"><sup>15</sup></a>. Los niveles de IL6, IL2R, IL10 y TNFÎ± suben discretamente o permanecen en rango normal en casos moderados pero muy elevados en casos severos (<a href="#fig0005">fig. 1</a> ). Este estudio parece apuntar que la tormenta de citoquinas se asocia con enfermedad COVID-19 severa de manera similar a como lo hacÃ­a en el sÃ­ndrome SARS-CoV. </p><div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Figura 1</span></a></div>   <p>Tormenta de citoquinas en la infecciÃ³n SARS-CoV-2.</p>   </div> <p /> <p id="par0065"><i>Persistencia de la respuesta neuroinflamatoria</i></p> <p id="par0070">Es relevante la pregunta de si la reacciÃ³n neuroinflamatoria ocurre de manera puntual o en determinadas circunstancias puede tener un carÃ¡cter persistente tras su puesta en marcha. En este sentido se sabe que las respuestas inmunes desreguladas tras infecciones pueden persistir en lo que se ha denominado sÃ­ndrome de inflamaciÃ³n-inmunosupresiÃ³n y catabolismo persistente. Se ha propuesto que esta situaciÃ³n inmunolÃ³gica especÃ­fica es iniciada por una tormenta de citoquinas durante fases agudas de cuadros infecciosos de forma similar a como ocurre en la enfermedad COVID-19 y es el resultado de la liberaciÃ³n continua de unas molÃ©culas a las que se ha llamado Â«alarminas endÃ³genasÂ» o Â«patrones moleculares asociados al peligroÂ» por parte de los Ã³rganos daÃ±ados que provoca una situaciÃ³n de inflamaciÃ³n crÃ³nica sistÃ©mica y un cambio en la producciÃ³n de cÃ©lulas madre de mÃ©dula Ã³sea hacia cÃ©lulas mieloides, lo que contribuye a la anemia crÃ³nica y la linfopenia<a href="#bib0285"><sup>16</sup></a>.</p> <p id="par0075">No existen, por razones obvias, datos concluyentes acerca de la posible apariciÃ³n de una situaciÃ³n de persistencia de inflamaciÃ³n en pacientes supervivientes a enfermedad COVID-19, pero dado que este sÃ­ndrome se relaciona con la gravedad del cuadro agudo, consideramos que serÃ­a una hipÃ³tesis plausible.</p> <p id="par0080"><i>Tormenta de citoquinas y sistema nervioso</i></p> <p id="par0085">Es conocido el efecto devastador que la tormenta de citoquinas produce a nivel del sistema respiratorio, fuente mayor de la letalidad del sÃ­ndrome. Sin embargo, una pregunta relevante como neurÃ³logos es si esta tormenta molecular que ocurre en la tercera fase de la enfermedad puede provocar afectaciÃ³n aguda o subaguda en el sistema nervioso central (SNC). Recientemente se ha descrito el caso de una mujer adulta con diagnostico de COVID-19 que tras unos dÃ­as de fiebre, tos y estado mental alterado ha derivado a una encefalopatÃ­a hemorrÃ¡gica necrosante aguda, una patologÃ­a poco frecuente que se relaciona con tormenta de citoquinas intracraneal y rotura de barrera hematoencefÃ¡lica aunque sin invasiÃ³n viral directa<a href="#bib0290"><sup>17</sup></a>.</p> <p id="par0090">Recurriendo a evidencias previas, se sabe que la neuroinflamaciÃ³n crÃ³nica asociada a elevados niveles de citoquinas/quimioquinas se han asociado con la fisiopatogenia de algunas enfermedades neurodegenerativas (END) tales como la esclerosis mÃºltiple, enfermedad de Parkinson, enfermedad de Alzheimer, enfermedad de Huntington o la esclerosis lateral amiotrÃ³fica<a href="#bib0295"><sup>18</sup></a>. En muchas ocasiones, los mecanismos inmunolÃ³gicos detonantes de la tormenta de citoquinas, tÃ­pica de los sÃ­ndromes SARS severos, juegan un papel relevante en el inicio de numerosas END, asÃ­ como en su progresiÃ³n.</p> <p id="par0095">AsÃ­, en el caso de la enfermedad de Alzheimer, se ha reportado que en presencia de citoquinas proinflamatorias (IL1 o IL6 fundamentalmente), la microglÃ­a pierde capacidad para fagocitar la proteÃ­na AÎ², responsable de los depÃ³sitos patogÃ©nicos de esta proteinopatÃ­a<a href="#bib0300"><sup>19</sup></a>. Esta observaciÃ³n apoya la idea de que la persistencia y acumulaciÃ³n de placas amiloides in vivo puede ser un resultado directo de la neuroinflamaciÃ³n. AdemÃ¡s, la cantidad de microglÃ­a con IL1Î± es mayor en las capas corticales afectadas por depÃ³sito de placas amiloides en pacientes con enfermedad de Alzheimer<a href="#bib0305"><sup>20</sup></a>.</p> <p id="par0100">Una serie de estudios han confirmado la presencia de mediadores inflamatorios (incluyendo TNF, IL-1Î², IL-6, e IFNÎ³) en el LCR de pacientes con enfermedad de Parkinson asÃ­ como en el cerebro de pacientes en estudios posmortem<a href="#bib0310">21</a>, <a href="#bib0315">22</a>. AdemÃ¡s, un interesante estudio muestra cÃ³mo los niveles de TNF se mantenÃ­an elevados en modelos de primate tratados con MPTP un aÃ±o despuÃ©s de la administraciÃ³n de la toxina, sugiriendo el papel de este biomarcador en la muestra neuronal asociada con el parkinsonismo de origen tÃ³xico<a href="#bib0320"><sup>23</sup></a>.</p> <p id="par0105">En el caso de la esclerosis mÃºltiple, se ha descrito la existencia de un incremento de la expresiÃ³n de citoquinas proinflamatorias (IFNÎ³, TNF, IL2, e IL22) y de molÃ©culas relacionadas con la actividad mantenida de linfocitos B y con la neogÃ©nesis linfoide (CXCL13, CXCL10, LTÎ±, IL6, e IL10). Estos factores han sido detectados en las meninges y en el LCR de casos de esclerosis mÃºltiple posmortem con altos niveles de inflamaciÃ³n menÃ­ngea. Similar patrÃ³n proinflamatorio incluyendo niveles de CXCL13, TNF, IFNÎ³, CXCL12, IL6, IL8, e IL10, se ha detectado en el LCR de pacientes de EM con alto nivel de daÃ±o en sustancia gris en el momento del diagnÃ³stico. De alguna manera estos datos apoyarÃ­an el papel de la neuroinflamaciÃ³n en la fase de neurodegeneraciÃ³n de esta enfermedad<a href="#bib0325"><sup>24</sup></a>.</p> <p id="par0110">Un caso singular es el de la patologÃ­a psiquiÃ¡trica, para la que tambiÃ©n se ha demostrado que la neuroinflamaciÃ³n constituye un factor patogÃ©nico de primer nivel. Los procesos neuroinflamatorios son capaces de producir cambios en el metabolismo de neurotransmisores, provocar desregulaciÃ³n del eje hipotÃ¡lamo-hipofisario-adrenal, activar la microglÃ­a, afectar a la neuroplasticidad y provocar cambios estructurales y funcionales en el cerebro, afectando a cogniciÃ³n y conducta. Se ha postulado que las citoquinas proinflamatorias son la base de la disrupciÃ³n de todos estos sistemas, estando en la base patogÃ©nica de trastornos afectivos, pero tambiÃ©n de procesos como la esquizofrenia, el trastorno bipolar y el consumo de drogas, en especial de alcohol<a href="#bib0330"><sup>25</sup></a>.</p> <p id="par0115">La idea de que los procesos de neuroinflamaciÃ³n juegan un papel importante en la fisiopatologÃ­a de cuadros neurolÃ³gicos de instauraciÃ³n aguda cada vez es mÃ¡s aceptada. Por ejemplo, en el caso de las crisis y/o sÃ­ndromes epilÃ©pticos es ampliamente reconocida, habiÃ©ndose descrito neuroinflamaciÃ³n secundaria a activaciÃ³n de la microglÃ­a y los astrocitos mediante la liberaciÃ³n de marcadores inflamatorios como IL-1Î², IL-6, y TNF en regiones como el hipocampo o el neocÃ³rtex<a href="#bib0335"><sup>26</sup></a>.</p> <p id="par0120">Por Ãºltimo, es conocida la base neuroinflamatoria de otros muchos procesos neurolÃ³gicos, entre los que podemos incluir prÃ¡cticamente toda la patologÃ­a neurolÃ³gica, desde cuadros encefalÃ­ticos inmunomediados o postinfecciosos, hasta la patologÃ­a cerebrovascular y, por supuesto enfermedades del sistema nervioso perifÃ©rico. En este sentido, no deja de ser llamativa la variable respuesta de acuerdo con la edad que presenta la infecciÃ³n por SARS-CoV-2 en la poblaciÃ³n, afectando en mayor severidad a los individuos de edad avanzada. La menor eficiencia y capacidad de respuesta de la inmunidad innata en edad avanzada es un hecho que aporta vulnerabilidad frente a una infecciÃ³n<a href="#bib0340"><sup>27</sup></a>. Son diversos los estudios que sugieren que el aumento del entorno proinflamatorio contribuye al desarrollo de enfermedades asociadas a la edad, demostrÃ¡ndose una relaciÃ³n entre la inmunosenescencia y su contribuciÃ³n a la neuroinflamaciÃ³n y el consiguiente desarrollo de la patologÃ­a neurodegenerativa, como, por ejemplo, ocurre en la enfermedad de Alzheimer donde la disfunciÃ³n microglial conlleva a una acumulaciÃ³n de AÎ² conducente a pÃ©rdida de respuesta inmune perifÃ©rica<a href="#bib0345"><sup>28</sup></a>.</p> <p id="par0125">Todo ello nos lleva a la conclusiÃ³n de que el sistema nervioso, tanto a nivel central como perifÃ©rico, puede considerarse como una diana preferente de los mecanismos neuroinflamatorios, con especial interÃ©s en la influencia que esta infecciÃ³n pudiera tener sobre la puesta en marcha o la progresiÃ³n de enfermedades neurodegenerativas.</p> <p id="par0130">Otro aspecto completamente desconocido que habrÃ¡ que vigilar es la posibilidad de que la infecciÃ³n aparentemente leve en niÃ±os y adolescentes pueda modificar en el largo plazo tanto las capacidades cognitivas como facilitar la apariciÃ³n de cuadros psiquiÃ¡tricos. La alteraciÃ³n del sistema inmunolÃ³gico ocasionado por el virus podrÃ­a dar lugar a modificaciones del pruning sinÃ¡ptico/celular durante la infancia y adolescencia, ocasionando problemas que solo se pondrÃ¡n de manifiesto en la edad adulta.</p> <p id="par0135"><i>Capacidad neuroinvasiva directa del SARS-CoV-2</i></p> <p id="par0140">Un tema de especial interÃ©s puede ser la posibilidad de que el SARS-COVID-19 tenga capacidad neuroinvasiva. Alguna evidencia se empieza a tener a este respecto.</p> <p id="par0145">El mecanismo molecular subyacente a invasiÃ³n celular del SARS-CoV-2 se relaciona con su habilidad para unirse selectivamente a los receptores de la enzima convertidora de la angiotensina 2 (ECA-2) de forma similar a como es conocido en el caso del SARS-CoV. Estos receptores presentan una alta expresiÃ³n en las cÃ©lulas epiteliales del sistema respiratorio e intestinal<a href="#bib0350">29</a>, <a href="#bib0355">30</a>, <a href="#bib0360">31</a>, <a href="#bib0365">32</a>, pero tambiÃ©n en el SNC, tanto en cÃ©lulas gliales, como en neuronas, lo que hace del SNC una diana potencial del SARS-CoV-2<a href="#bib0370"><sup>33</sup></a>. AdemÃ¡s, estudios previos han demostrado la capacidad de este virus para causar muerte neuronal en ratones a travÃ©s de la invasiÃ³n del SNC por la lÃ¡mina cribiforme del etmoides y la posterior invasiÃ³n del neuroepitelio olfatorio<a href="#bib0375"><sup>34</sup></a>.</p> <p id="par0150">TambiÃ©n existe la posibilidad de invasiÃ³n del SNC por vÃ­a hematÃ³gena. La presencia del COVID-19 en la circulaciÃ³n general estÃ¡ comprobada. Siendo esto cierto, a nivel cerebral, el movimiento lento de la sangre dentro de la microcirculaciÃ³n podrÃ­a ser uno de los factores que pueden facilitar la interacciÃ³n del virus con ACE2 expresada en el endotelio capilar<a href="#bib0355"><sup>30</sup></a>. Interesantemente, este mecanismo puede estar involucrado con el daÃ±o endotelial y subsecuente tendencia al sangrado cerebral que se ha observado en pacientes durante las fases agudas de la enfermedad COVID-19.</p> <p id="par0155">AdemÃ¡s, algunas evidencias preliminares sugieren que la capacidad neuroinvasiva del virus podrÃ­a tener implicaciones pronÃ³sticas incluso en fase aguda. En este sentido, se especula con la posibilidad de que la causa de la muerte en casos de afectaciÃ³n respiratoria severa estÃ¡ mediada, al menos en parte, por la existencia de un sÃ­ndrome de hipoventilaciÃ³n central secundario a la invasiÃ³n del SNC<a href="#bib0380"><sup>35</sup></a>.</p> <p id="par0160">Una revisiÃ³n retrospectiva sobre pacientes asistidos en Wuhan analiza la sintomatologÃ­a neurolÃ³gica de 214 pacientes consecutivos, describiendo la existencia de un 36,4% de pacientes con sÃ­ntomas neurolÃ³gicos, fundamentalmente en pacientes con afectaciÃ³n severa, siendo los sÃ­ntomas mÃ¡s reportados, el deterioro de conciencia, los ictus en fase aguda (tanto isquÃ©mico como hemorrÃ¡gico) y el daÃ±o muscular esquelÃ©tico<a href="#bib0385"><sup>36</sup></a>.</p> <p id="par0165">Con posterioridad, se han descrito algunos casos en los que hubo evidencia de invasiÃ³n del virus en el SNC. AsÃ­ el equipo del Beijing Ditan Hospital confirmÃ³ la presencia de SARS-CoV-2 en el LCR de pacientes con enfermedad COVID-19 a travÃ©s de secuenciaciÃ³n genÃ³mica en un paciente con una encefalitis clÃ­nica<a href="#bib0390"><sup>37</sup></a>.</p> <p id="par0170">Nada se sabe de la posible persistencia del SARS-CoV-2 en el SNC a medio o largo plazo. Pero sÃ­ se ha descrito esta propiedad en otros virus, incluso dentro de su misma categorÃ­a. AsÃ­, el HCoV-OC43RNA, un coronavirus humano, mostrÃ³ que podÃ­a ser detectado en el SNC de un modelo murino de encefalitis por coronavirus durante mÃ¡s de un aÃ±o despuÃ©s de la inoculaciÃ³n<a href="#bib0395"><sup>38</sup></a>.</p> <p id="par0175">La pregunta de por quÃ© esto es posible en el sistema nervioso es objeto de debate. AsÃ­, se propone que las estrategias citolÃ­ticas e inflamatorias que son efectivas en el control de las infecciones virales en otros Ã³rganos, no pueden ser empleadas por nuestro sistema inmune en el cerebro por las devastadoras consecuencias que ocasionarÃ­an. Tal vez por esta razÃ³n, el sistema inmunolÃ³gico arbitra otro tipo de respuestas a nivel del SNC que favorecen que algunos virus permanezcan acantonados en el mismo y puedan reactivarse al cabo de un tiempo en situaciones favorables para el virus<a href="#bib0400"><sup>39</sup></a>.</p> <p id="par0180">No es descartable que el SARS-CoV-2 pueda pertenecer a este grupo de virus. De ser asÃ­, no serÃ­a descartable la apariciÃ³n de manifestaciones neurolÃ³gicas relacionadas con la reactivaciÃ³n del virus a medio o largo plazo que podrÃ­an suponer la reactivaciÃ³n de los procesos neuroinflamatorios y de toda la cascada descrita fundamentalmente en pacientes con END.</p> <p id="par0185"><i>ActuaciÃ³n indirecta del SARS-CoV-2 sobre el SNC</i></p> <p id="par0190">La infecciÃ³n por SARS-CoV-2 sobre otros Ã³rganos podrÃ­a, de forma indirecta, tener incidencia sobre el SNC y mÃ¡s concretamente sobre el desarrollo de END. AsÃ­, en los Ãºltimos aÃ±os se ha objetivado una estrecha relaciÃ³n entre la microbiota intestinal y la neuroinflamaciÃ³n con enfermedades del SNC. Sabemos que el SARS-CoV-2 invade las cÃ©lulas de la mucosa intestinal provocando fenÃ³menos inflamatorios y disbiosis intestinal, pudiendo alterar la microbiota tanto a corto como a largo plazo que podrÃ­an contribuir a la neuroinflamaciÃ³n y por ende faciliten la neurodegeneraciÃ³n y la apariciÃ³n de END<a href="#bib0405"><sup>40</sup></a>.</p> </div> <div class="conclusiones" title="sec"> <div class="title" tagx="title" title="title">
Conclusiones</div> <p id="par0195">La irrupciÃ³n de la pandemia COVID-19Â ha supuesto un problema de salud pÃºblica de dimensiones Ã©picas no conocido en la historia reciente de la humanidad, no solo por la extensiÃ³n de la infecciÃ³n entre la poblaciÃ³n o por su letalidad aguda asociada, sino tambiÃ©n por los interrogantes que despierta sobre su posible evoluciÃ³n a medio o largo plazo.</p> <p id="par0200">En este sentido, existen una serie de indicios que nos hacen pensar que el sistema nervioso no va a ser precisamente ajeno a esta infecciÃ³n y puede que adquiera protagonismo en el futuro.</p> <p id="par0205">Una reciente revisiÃ³n publicada en castellano, ya insiste en este problema incidiendo fundamentalmente en patologÃ­a directa derivada de la infecciÃ³n por SARS-CoV-2<a href="#bib0410"><sup>41</sup></a>. Nuestro trabajo puede ser considerado complementario a este, centrÃ¡ndose en aspectos relacionados con la incidencia sobre patologÃ­as neurolÃ³gicas con base patogÃ©nica neuroinflamatoria.</p> <p id="par0210">El SARS-CoV-2 provoca una tormenta de citoquinas cuyos efectos sobre el SNC pueden tener consecuencias imprevisibles de forma aguda, pero tambiÃ©n de manera demorada en el tiempo. AsÃ­, es conocido que mÃºltiples enfermedades neurolÃ³gicas incluyen entre sus mecanismos patogÃ©nicos una base neuroinflamatoria que involucra precisamente a los factores que son estimulados en la tercera fase de la enfermedad aguda COVID-19. De especial relevancia es la repercusiÃ³n que este movimiento molecular pudiera tener en la puesta en marcha y progresiÃ³n de determinadas END como la enfermedad de Alzheimer, la enfermedad de Parkinson o la esclerosis mÃºltiple en su fase neurodegenerativa y tambiÃ©n sobre enfermedades psiquiÃ¡tricas en las que los mecanismos neuroinflamatorios han adquirido relevancia en los Ãºltimos tiempos, en especial los trastornos afectivos. SerÃ¡ especialmente importante el seguimiento desde el punto de vista cognitivo y psiquiÃ¡trico de los pacientes supervivientes a una enfermedad COVID-19 severa, mÃ¡xime teniendo en cuenta que se sabe que la situaciÃ³n de desregulaciÃ³n neuroinflamatoria puede ser persistente en casos de enfermedad severa siguiendo el modelo denominado sÃ­ndrome de inflamaciÃ³n-inmunosupresiÃ³n y catabolismo persistente.</p> <p id="par0215">AdemÃ¡s, el SARS-CoV-2 tiene capacidad neuroinvasiva directa. Gracias a la experiencia con el SARS-CoV, se conocen aceptablemente los mecanismos de invasiÃ³n del SNC que puede usar el virus. Es especialmente interesante desde el punto de vista evolutivo conocer cÃ³mo se va a comportar el virus en el SNC una vez se produjo la invasiÃ³n. Si el virus es capaz de mantenerse latente en el SNC de forma similar a como lo hacen otros coronavirus, no serÃ­a descartable que permaneciera y se potenciara tambiÃ©n la cascada inflamatoria descrita, con su posible influencia sobre el inicio y desarrollo de END.</p> <p id="par0220">Somos conscientes de que este trabajo tiene un fuerte componente especulativo, pero si las hipÃ³tesis esbozadas fueran realidad, la magnitud de la pandemia neurolÃ³gica a medio plazo podrÃ­a ser muy importante, pues inducirÃ­a la puesta en marcha o la aceleraciÃ³n de los mecanismos bÃ¡sicos de las END en pacientes predispuestos desde el punto de vista genÃ©tico o ambiental dentro del amplio grupo de poblaciÃ³n que sea finalmente infectado, ademÃ¡s de los efectos directos que sobre el sistema nervioso podrÃ­a tener la respuesta neuroinflamatoria y la invasiÃ³n directa del virus.</p> <p id="par0225">La NeurologÃ­a no puede interpretar la enfermedad COVID-19 como una pandemia ajena a la especialidad. Al contrario, es previsible que sus repercusiones le involucren de manera directa a medio plazo, tanto desde el punto de vista asistencial como investigador.</p> <p id="par0230">Neuro-RECA ha diseÃ±ado un proyecto de investigaciÃ³n colaborativo multicÃ©ntrico que pretende seguir prospectivamente a los pacientes supervivientes a una infecciÃ³n severa por COVID-19 desde el punto de vista cognitivo, psiquiÃ¡trico, virolÃ³gico, neurofisiolÃ³gico y de calidad de vida en el aÃ±o posterior a su alta hospitalaria que pretende desentraÃ±ar buena parte de los interrogantes vertidos en este artÃ­culo.</p> </div> <div class="conflictodeintereses" title="sec"> <div class="title" tagx="title" title="title">
Conflicto de intereses</div> <p id="par0235">Los autores declaran no tener ningÃºn conflicto de intereses.</p> </div> </div> <div class="back" title="back"> <div class="references">
References</div> <div tag="ref-list"> <ul> <div class="title" tagx="title" title="title">
BibliografÃ­a</div> <li tag="ref"><a name="bib0210" /><span class="label" tagx="label" title="label">1</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Li</span><span class="given-names" tagx="given-names" title="given-names">Q.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Guan</span><span class="given-names" tagx="given-names" title="given-names">X.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wu</span><span class="given-names" tagx="given-names" title="given-names">P.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wang</span><span class="given-names" tagx="given-names" title="given-names">X.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhou</span><span class="given-names" tagx="given-names" title="given-names">L.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Tong</span><span class="given-names" tagx="given-names" title="given-names">Y.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia</span><span class="source" tagx="source" title="source">N Engl J Med.</span><span class="volume" tagx="volume" title="volume">382</span><span class="year" tagx="year" title="year">2020</span><span class="fpage" tagx="fpage" title="fpage">1199</span><span class="lpage" tagx="lpage" title="lpage">1207</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/31995857">31995857</a></span></span></li> <li tag="ref"><a name="bib0215" /><span class="label" tagx="label" title="label">2</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation">CDC. 2019 Novel coronavirus, Wuhan, China. 2020. [consultado 11 Abr 2020]. Disponible en: https://www.cdc.gov/coronavirus/2019-nCoV/summary.html.</span></li> <li tag="ref"><a name="bib0220" /><span class="label" tagx="label" title="label">3</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation">WHO. Novel Coronavirusâ€"China. 2020. [consultado 11 Abr 2020]. Disponible en: https://www.who.int/csr/don/12-january-2020-novel-coronavirus-china/en/.</span></li> <li tag="ref"><a name="bib0225" /><span class="label" tagx="label" title="label">4</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ensheng</span><span class="given-names" tagx="given-names" title="given-names">D.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hongru</span><span class="given-names" tagx="given-names" title="given-names">D.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Gardner L:</span></span></span><span class="mixed-article-title" title="mixed-article-title">An interactive web-based dashboard to track COVID-19 in real time</span><span class="source" tagx="source" title="source">Lancet Infect Dis. 2020</span><span class="year" tagx="year" title="year">2020 Feb 19</span><span class="pub-id"><a href="https://dx.doi.org/10.1016/S1473-3099(20)30120-1">10.1016/S1473-3099(20)30120-1</a></span><span class="comment">pii: S1473-3099(20)30120-1.</span></span></li> <li tag="ref"><a name="bib0230" /><span class="label" tagx="label" title="label">5</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation">WHO Cumulative number of reported probable cases of SARS. In: 2003 15 [consultado 16 Abr 2020]. Disponible en: <a href="http://www.who.int/csr/disease/coronavirus_infections/MERS_CoV_RA_20140613.pdf">http://www.who.int/csr/disease/coronavirus_infections/MERS_CoV_RA_20140613.pdf</a></span></li> <li tag="ref"><a name="bib0235" /><span class="label" tagx="label" title="label">6</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation">WHO: Middle East respiratory syndrome coronavirus (MERSCoV). [consultado 11 Abr 2020]. Disponible en: http://www.who.int/emergencies/mers-cov/en/.</span></li> <li tag="ref"><a name="bib0240" /><span class="label" tagx="label" title="label">7</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kuiken</span><span class="given-names" tagx="given-names" title="given-names">T.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Fouchier</span><span class="given-names" tagx="given-names" title="given-names">R.A.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Schutten</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Rimmelzwaan</span><span class="given-names" tagx="given-names" title="given-names">G.F.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">van Amerongen</span><span class="given-names" tagx="given-names" title="given-names">G.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">van Riel</span><span class="given-names" tagx="given-names" title="given-names">D.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome</span><span class="source" tagx="source" title="source">Lancet</span><span class="volume" tagx="volume" title="volume">362</span><span class="year" tagx="year" title="year">2003</span><span class="fpage" tagx="fpage" title="fpage">263</span><span class="lpage" tagx="lpage" title="lpage">270</span><span class="comment">10</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/12892955">12892955</a></span></span></li> <li tag="ref"><a name="bib0245" /><span class="label" tagx="label" title="label">8</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Peiris</span><span class="given-names" tagx="given-names" title="given-names">J.S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lai</span><span class="given-names" tagx="given-names" title="given-names">S.T.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Poon</span><span class="given-names" tagx="given-names" title="given-names">L.L.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Guan</span><span class="given-names" tagx="given-names" title="given-names">Y.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yam</span><span class="given-names" tagx="given-names" title="given-names">L.Y.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lim</span><span class="given-names" tagx="given-names" title="given-names">W.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Coronavirus as a possible cause of severe acute respiratory syndrome</span><span class="source" tagx="source" title="source">Lancet</span><span class="volume" tagx="volume" title="volume">361</span><span class="year" tagx="year" title="year">2003</span><span class="fpage" tagx="fpage" title="fpage">1319</span><span class="lpage" tagx="lpage" title="lpage">1325</span><span class="comment">11</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/12711465">12711465</a></span></span></li> <li tag="ref"><a name="bib0250" /><span class="label" tagx="label" title="label">9</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Nicholls</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Dong</span><span class="given-names" tagx="given-names" title="given-names">X.P.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Jiang</span><span class="given-names" tagx="given-names" title="given-names">G.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Peiris</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span></span><span class="mixed-article-title" title="mixed-article-title">SARS: clinical virology and pathogenesis</span><span class="source" tagx="source" title="source">Respirology</span><span class="volume" tagx="volume" title="volume">8</span><span class="issue" tagx="issue" title="issue">Suppl</span><span class="year" tagx="year" title="year">2003</span><span class="fpage" tagx="fpage" title="fpage">S6</span><span class="lpage" tagx="lpage" title="lpage">S8</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/15018126">15018126</a></span></span></li> <li tag="ref"><a name="bib0255" /><span class="label" tagx="label" title="label">10</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">van den Brand</span><span class="given-names" tagx="given-names" title="given-names">J.M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Haagmans</span><span class="given-names" tagx="given-names" title="given-names">B.L.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">van Riel</span><span class="given-names" tagx="given-names" title="given-names">D.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Osterhaus</span><span class="given-names" tagx="given-names" title="given-names">A.D.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kuiken</span><span class="given-names" tagx="given-names" title="given-names">T.</span></span></span><span class="mixed-article-title" title="mixed-article-title">The pathology and pathogenesis of experimental severe acute respiratory syndrome and influenza in animal models</span><span class="source" tagx="source" title="source">J Comp Pathol</span><span class="volume" tagx="volume" title="volume">151</span><span class="year" tagx="year" title="year">2014</span><span class="fpage" tagx="fpage" title="fpage">83</span><span class="lpage" tagx="lpage" title="lpage">112</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/24581932">24581932</a></span></span></li> <li tag="ref"><a name="bib0260" /><span class="label" tagx="label" title="label">11</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation">Channappanavar R., Fehr AR, Vijay R, Mack M, Zhao J, Meyerholz DK, et al. Dysregulated type I interferon and inflammatory monocyte-macrophage responses cause lethal pneumonia in SARS-CoV-infected mice. Cell Host Microbe 2016:19 (2): 181-193.</span></li> <li tag="ref"><a name="bib0265" /><span class="label" tagx="label" title="label">12</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Davidson</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Maini</span><span class="given-names" tagx="given-names" title="given-names">M.K.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wack</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Disease-promoting effects of type I interferons in viral, bacterial, and coinfections</span><span class="source" tagx="source" title="source">J Interf Cytokine Res</span><span class="volume" tagx="volume" title="volume">35</span><span class="year" tagx="year" title="year">2015</span><span class="fpage" tagx="fpage" title="fpage">252</span><span class="lpage" tagx="lpage" title="lpage">264</span></span></li> <li tag="ref"><a name="bib0270" /><span class="label" tagx="label" title="label">13</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Channappanavar</span><span class="given-names" tagx="given-names" title="given-names">R.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Perlman</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology</span><span class="source" tagx="source" title="source">Semin Immunopathol.</span><span class="volume" tagx="volume" title="volume">39</span><span class="year" tagx="year" title="year">2017</span><span class="fpage" tagx="fpage" title="fpage">529</span><span class="lpage" tagx="lpage" title="lpage">539</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/28466096">28466096</a></span></span></li> <li tag="ref"><a name="bib0275" /><span class="label" tagx="label" title="label">14</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Chien</span><span class="given-names" tagx="given-names" title="given-names">J.Y.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hsueh</span><span class="given-names" tagx="given-names" title="given-names">P.R.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Cheng</span><span class="given-names" tagx="given-names" title="given-names">W.C.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yu</span><span class="given-names" tagx="given-names" title="given-names">C.J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yang</span><span class="given-names" tagx="given-names" title="given-names">P.C.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Temporal changes in cytokine/chemokine profiles and pulmonary involvement in severe acute respiratory syndrome</span><span class="source" tagx="source" title="source">Respirology</span><span class="volume" tagx="volume" title="volume">11</span><span class="year" tagx="year" title="year">2006</span><span class="fpage" tagx="fpage" title="fpage">715</span><span class="lpage" tagx="lpage" title="lpage">722</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/17052299">17052299</a></span></span></li> <li tag="ref"><a name="bib0280" /><span class="label" tagx="label" title="label">15</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Chen</span><span class="given-names" tagx="given-names" title="given-names">G.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wu</span><span class="given-names" tagx="given-names" title="given-names">D.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Guo</span><span class="given-names" tagx="given-names" title="given-names">W.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Cao</span><span class="given-names" tagx="given-names" title="given-names">Y.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Huang</span><span class="given-names" tagx="given-names" title="given-names">D.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wang</span><span class="given-names" tagx="given-names" title="given-names">H.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Clinical and Immunologic features in severe and moderate Coronavirus Disease 2019</span><span class="source" tagx="source" title="source">J Clin Invest.</span><span class="year" tagx="year" title="year">2020</span><span class="comment">pii: 137244. doi: 10.1172/JCI137244</span></span></li> <li tag="ref"><a name="bib0285" /><span class="label" tagx="label" title="label">16</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hawkins</span><span class="given-names" tagx="given-names" title="given-names">R.B.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Raymond</span><span class="given-names" tagx="given-names" title="given-names">S.L.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Stortz</span><span class="given-names" tagx="given-names" title="given-names">J.A.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Horiguchi</span><span class="given-names" tagx="given-names" title="given-names">H.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Brakenridge</span><span class="given-names" tagx="given-names" title="given-names">S.C.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Gardner</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Chronic critical illness and the persistent inflammation, immunosuppression, and catabolism syndrome</span><span class="source" tagx="source" title="source">Front Immunol.</span><span class="volume" tagx="volume" title="volume">9</span><span class="year" tagx="year" title="year">2018</span><span class="fpage" tagx="fpage" title="fpage">1511</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/30013565">30013565</a></span></span></li> <li tag="ref"><a name="bib0290" /><span class="label" tagx="label" title="label">17</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Poyiadji</span><span class="given-names" tagx="given-names" title="given-names">N.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Shahin</span><span class="given-names" tagx="given-names" title="given-names">G.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Noujaim</span><span class="given-names" tagx="given-names" title="given-names">D.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Stone</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Patel</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Griffith</span><span class="given-names" tagx="given-names" title="given-names">B.</span></span></span><span class="mixed-article-title" title="mixed-article-title">COVID-19-associated Acute Hemorrhagic Necrotizing Encephalopathy: CT and MRI Features</span><span class="source" tagx="source" title="source">Radiology.</span><span class="volume" tagx="volume" title="volume">31</span><span class="year" tagx="year" title="year">2020</span><span class="fpage" tagx="fpage" title="fpage">201187</span></span></li> <li tag="ref"><a name="bib0295" /><span class="label" tagx="label" title="label">18</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Frank-Cannon TC1</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Alto</span><span class="given-names" tagx="given-names" title="given-names">L.T.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">McAlpine</span><span class="given-names" tagx="given-names" title="given-names">F.E.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Tansey</span><span class="given-names" tagx="given-names" title="given-names">M.G.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Does neuroinflammation fan the flame in neurodegenerative diseases?</span><span class="source" tagx="source" title="source">Mol Neurodegener.</span><span class="volume" tagx="volume" title="volume">4</span><span class="year" tagx="year" title="year">2009</span><span class="fpage" tagx="fpage" title="fpage">47</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/19917131">19917131</a></span></span></li> <li tag="ref"><a name="bib0300" /><span class="label" tagx="label" title="label">19</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Koenigsknecht-Talboo</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Landreth GE</span></span></span><span class="mixed-article-title" title="mixed-article-title">Microglial phagocytosis induced by fibrillar beta-amyloid and IgGs are differentially regulated by proinflammatory cytokines</span><span class="source" tagx="source" title="source">J Neurosci</span><span class="volume" tagx="volume" title="volume">25</span><span class="year" tagx="year" title="year">2005</span><span class="fpage" tagx="fpage" title="fpage">8240</span><span class="lpage" tagx="lpage" title="lpage">8249</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/16148231">16148231</a></span></span></li> <li tag="ref"><a name="bib0305" /><span class="label" tagx="label" title="label">20</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Sheng</span><span class="given-names" tagx="given-names" title="given-names">J.G.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Griffin</span><span class="given-names" tagx="given-names" title="given-names">W.S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Royston</span><span class="given-names" tagx="given-names" title="given-names">M.C.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Mrak RE</span></span></span><span class="mixed-article-title" title="mixed-article-title">Distribution of inter-leukin-1-immunoreactive microglia in cerebral cortical lay-ers: implications for neuritic plaque formation in Alzheimer's disease</span><span class="source" tagx="source" title="source">Neuropathol Appl Neurobiol</span><span class="volume" tagx="volume" title="volume">24</span><span class="year" tagx="year" title="year">1998</span><span class="fpage" tagx="fpage" title="fpage">278</span><span class="lpage" tagx="lpage" title="lpage">283</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/9775393">9775393</a></span></span></li> <li tag="ref"><a name="bib0310" /><span class="label" tagx="label" title="label">21</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">McGeer</span><span class="given-names" tagx="given-names" title="given-names">P.L.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Itagaki</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Boyes</span><span class="given-names" tagx="given-names" title="given-names">B.E.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">McGeer EG:</span></span></span><span class="mixed-article-title" title="mixed-article-title">Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains</span><span class="source" tagx="source" title="source">Neurology</span><span class="volume" tagx="volume" title="volume">38</span><span class="year" tagx="year" title="year">1988</span><span class="fpage" tagx="fpage" title="fpage">1285</span><span class="lpage" tagx="lpage" title="lpage">1291</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/3399080">3399080</a></span></span></li> <li tag="ref"><a name="bib0315" /><span class="label" tagx="label" title="label">22</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Vawter</span><span class="given-names" tagx="given-names" title="given-names">M.P.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Dillon-Carter</span><span class="given-names" tagx="given-names" title="given-names">O.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Tourtellotte</span><span class="given-names" tagx="given-names" title="given-names">W.W.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Carvey</span><span class="given-names" tagx="given-names" title="given-names">P.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Freed WJ</span></span></span><span class="mixed-article-title" title="mixed-article-title">TGFbeta1 and TGFbeta2 concentrations are elevated in Parkinson's disease in ventricular cerebrospinal fluid</span><span class="source" tagx="source" title="source">Exp Neurol</span><span class="volume" tagx="volume" title="volume">142</span><span class="year" tagx="year" title="year">1996</span><span class="fpage" tagx="fpage" title="fpage">313</span><span class="lpage" tagx="lpage" title="lpage">322</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/8934562">8934562</a></span></span></li> <li tag="ref"><a name="bib0320" /><span class="label" tagx="label" title="label">23</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Barcia</span><span class="given-names" tagx="given-names" title="given-names">C.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">de Pablos</span><span class="given-names" tagx="given-names" title="given-names">V.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Bautista-Hernandez</span><span class="given-names" tagx="given-names" title="given-names">V.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Sanchez-Bahillo</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Bernal</span><span class="given-names" tagx="given-names" title="given-names">I.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Fernandez-Villalba</span><span class="given-names" tagx="given-names" title="given-names">E.et al.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Increased plasma levels of TNF-alpha but not of IL1-beta in MPTP-treated monkeys one year after the MPTP administration</span><span class="source" tagx="source" title="source">Parkinsonism Relat Disord</span><span class="volume" tagx="volume" title="volume">11</span><span class="year" tagx="year" title="year">2005</span><span class="fpage" tagx="fpage" title="fpage">435</span><span class="lpage" tagx="lpage" title="lpage">439</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/16154791">16154791</a></span></span></li> <li tag="ref"><a name="bib0325" /><span class="label" tagx="label" title="label">24</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Magliozzi</span><span class="given-names" tagx="given-names" title="given-names">R.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Howell</span><span class="given-names" tagx="given-names" title="given-names">O.W.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Nicholas</span><span class="given-names" tagx="given-names" title="given-names">R.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Cruciani</span><span class="given-names" tagx="given-names" title="given-names">C.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Castellaro</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Romualdi</span><span class="given-names" tagx="given-names" title="given-names">C</span></span></span><span class="mixed-article-title" title="mixed-article-title">Inflammatory intrathecal profiles and cortical damage in multiple sclerosis</span><span class="source" tagx="source" title="source">Ann Neurol.</span><span class="volume" tagx="volume" title="volume">83</span><span class="year" tagx="year" title="year">2018</span><span class="fpage" tagx="fpage" title="fpage">739</span><span class="lpage" tagx="lpage" title="lpage">755</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/29518260">29518260</a></span></span></li> <li tag="ref"><a name="bib0330" /><span class="label" tagx="label" title="label">25</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Rhie</span><span class="given-names" tagx="given-names" title="given-names">S.J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Jung</span><span class="given-names" tagx="given-names" title="given-names">E.Y.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Shim</span><span class="given-names" tagx="given-names" title="given-names">I.</span></span></span><span class="mixed-article-title" title="mixed-article-title">The role of neuroinflammation on pathogenesis of affective disorders</span><span class="source" tagx="source" title="source">J Exerc Rehabil.</span><span class="volume" tagx="volume" title="volume">16</span><span class="year" tagx="year" title="year">2020</span><span class="fpage" tagx="fpage" title="fpage">2</span><span class="lpage" tagx="lpage" title="lpage">9</span><span class="pub-id"><a href="https://dx.doi.org/10.12965/jer.2040016.008">10.12965/jer.2040016.008</a></span><span class="comment">eCollection 2020 Feb</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32161729">32161729</a></span></span></li> <li tag="ref"><a name="bib0335" /><span class="label" tagx="label" title="label">26</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Reddy</span><span class="given-names" tagx="given-names" title="given-names">D.S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kuruba</span><span class="given-names" tagx="given-names" title="given-names">R.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Experimental models of status epilepticus and neuronal injury for evaluation of therapeutic interventions</span><span class="source" tagx="source" title="source">Int J Mol Sci.</span><span class="volume" tagx="volume" title="volume">14</span><span class="year" tagx="year" title="year">2013</span><span class="fpage" tagx="fpage" title="fpage">18284</span><span class="lpage" tagx="lpage" title="lpage">18318</span><span class="pub-id"><a href="https://dx.doi.org/10.3390/ijms140918284">10.3390/ijms140918284</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/24013377">24013377</a></span></span></li> <li tag="ref"><a name="bib0340" /><span class="label" tagx="label" title="label">27</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Boe</span><span class="given-names" tagx="given-names" title="given-names">D.M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Boule</span><span class="given-names" tagx="given-names" title="given-names">L.A.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kovacs</span><span class="given-names" tagx="given-names" title="given-names">E.J.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Innate immune responses in the ageing lung</span><span class="source" tagx="source" title="source">Clin. Exp. Immunol.</span><span class="volume" tagx="volume" title="volume">187</span><span class="year" tagx="year" title="year">2017</span><span class="fpage" tagx="fpage" title="fpage">16</span><span class="lpage" tagx="lpage" title="lpage">25</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/27711979">27711979</a></span></span></li> <li tag="ref"><a name="bib0345" /><span class="label" tagx="label" title="label">28</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Costantini</span><span class="given-names" tagx="given-names" title="given-names">E.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Dâ€™Angelo</span><span class="given-names" tagx="given-names" title="given-names">C.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Reale</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span></span><span class="mixed-article-title" title="mixed-article-title">The Role of Immunosenescence in Neurodegenerative Diseases</span><span class="source" tagx="source" title="source">Mediators Inflamm.</span><span class="volume" tagx="volume" title="volume">2018</span><span class="year" tagx="year" title="year">2018</span><span class="fpage" tagx="fpage" title="fpage">6039171</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/29706800">29706800</a></span></span></li> <li tag="ref"><a name="bib0350" /><span class="label" tagx="label" title="label">29</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Xu</span><span class="given-names" tagx="given-names" title="given-names">H.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhong</span><span class="given-names" tagx="given-names" title="given-names">L.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Deng</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Peng</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Dan</span><span class="given-names" tagx="given-names" title="given-names">H.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zeng</span><span class="given-names" tagx="given-names" title="given-names">X.et al.</span></span></span><span class="mixed-article-title" title="mixed-article-title">High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa</span><span class="source" tagx="source" title="source">Int J Oral Sci.</span><span class="volume" tagx="volume" title="volume">12</span><span class="year" tagx="year" title="year">2020</span><span class="fpage" tagx="fpage" title="fpage">8</span><span class="pub-id"><a href="https://dx.doi.org/10.1038/s41368-020-0074-x">10.1038/s41368-020-0074-x</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32094336">32094336</a></span></span></li> <li tag="ref"><a name="bib0355" /><span class="label" tagx="label" title="label">30</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhang</span><span class="given-names" tagx="given-names" title="given-names">H.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Penninger</span><span class="given-names" tagx="given-names" title="given-names">J.M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Li</span><span class="given-names" tagx="given-names" title="given-names">Y.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhong</span><span class="given-names" tagx="given-names" title="given-names">N.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Slutsky</span><span class="given-names" tagx="given-names" title="given-names">A.S.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target</span><span class="source" tagx="source" title="source">Intensive Care Med.</span><span class="volume" tagx="volume" title="volume">46</span><span class="year" tagx="year" title="year">2020 Apr</span><span class="fpage" tagx="fpage" title="fpage">586</span><span class="lpage" tagx="lpage" title="lpage">590</span><span class="pub-id"><a href="https://dx.doi.org/10.1007/s00134-020-05985-9">10.1007/s00134-020-05985-9</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32125455">32125455</a></span></span></li> <li tag="ref"><a name="bib0360" /><span class="label" tagx="label" title="label">31</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lukassen</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lorenz Chua</span><span class="given-names" tagx="given-names" title="given-names">R.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Trefzer</span><span class="given-names" tagx="given-names" title="given-names">T.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kahn</span><span class="given-names" tagx="given-names" title="given-names">N.C.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Schneider</span><span class="given-names" tagx="given-names" title="given-names">M.A.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Muley</span><span class="given-names" tagx="given-names" title="given-names">T.et al.</span></span></span><span class="mixed-article-title" title="mixed-article-title">SARS-CoV-2 receptor ACE2 and TMPRSS2 are primarily expressed in bronchial transient secretory cells</span><span class="source" tagx="source" title="source">EMBO J.</span><span class="year" tagx="year" title="year">2020</span><span class="pub-id"><a href="https://dx.doi.org/10.15252/embj.20105114">10.15252/embj.20105114</a></span></span></li> <li tag="ref"><a name="bib0365" /><span class="label" tagx="label" title="label">32</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wong</span><span class="given-names" tagx="given-names" title="given-names">S.H.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lui</span><span class="given-names" tagx="given-names" title="given-names">R.N.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Sung</span><span class="given-names" tagx="given-names" title="given-names">J.J.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Covid-19 and the Digestive System</span><span class="source" tagx="source" title="source">J Gastroenterol Hepatol.</span><span class="year" tagx="year" title="year">2020</span><span class="pub-id"><a href="https://dx.doi.org/10.1111/jgh.15047">10.1111/jgh.15047</a></span></span></li> <li tag="ref"><a name="bib0370" /><span class="label" tagx="label" title="label">33</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Baig</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Khaleeq</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ali</span><span class="given-names" tagx="given-names" title="given-names">U.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Syeda</span><span class="given-names" tagx="given-names" title="given-names">H.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution. Hostâ€"Virus Interaction, and Proposed Neurotropic Mechanisms</span><span class="source" tagx="source" title="source">ACS Chem Neurosc</span><span class="year" tagx="year" title="year">2020</span><span class="pub-id"><a href="https://dx.doi.org/10.1021/acschemneuro.0c00122">10.1021/acschemneuro.0c00122</a></span></span></li> <li tag="ref"><a name="bib0375" /><span class="label" tagx="label" title="label">34</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Netland</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Meyerholz</span><span class="given-names" tagx="given-names" title="given-names">D.K.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Moore</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Cassell</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Perlman</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2</span><span class="source" tagx="source" title="source">J Virol.</span><span class="volume" tagx="volume" title="volume">82</span><span class="year" tagx="year" title="year">2008</span><span class="fpage" tagx="fpage" title="fpage">7264</span><span class="lpage" tagx="lpage" title="lpage">7275</span><span class="pub-id" /><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/18495771">18495771</a></span></span></li> <li tag="ref"><a name="bib0380" /><span class="label" tagx="label" title="label">35</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Li</span><span class="given-names" tagx="given-names" title="given-names">Y.C.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Bai</span><span class="given-names" tagx="given-names" title="given-names">W.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hashikawa T:</span></span></span><span class="mixed-article-title" title="mixed-article-title">The neuroinvasive potential of SARS-CoV2 may be at least partially responsible for the respiratory failure of COVID-19 patients</span><span class="source" tagx="source" title="source">T J Med Virol.</span><span class="year" tagx="year" title="year">2020</span><span class="pub-id" /></span></li> <li tag="ref"><a name="bib0385" /><span class="label" tagx="label" title="label">36</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Mao</span><span class="given-names" tagx="given-names" title="given-names">L.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wang</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Chen</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">He</span><span class="given-names" tagx="given-names" title="given-names">Q.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Chang</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hong</span><span class="given-names" tagx="given-names" title="given-names">C.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Neurological manifestations of hospitalized patients with COVID-19 in Wuhan, China: a retrospective case series study</span><span class="source" tagx="source" title="source">MedRXiv</span><span class="year" tagx="year" title="year">2020</span><span class="pub-id"><a href="https://dx.doi.org/10.1101/2020.02.22.20026500">10.1101/2020.02.22.20026500</a></span></span></li> <li tag="ref"><a name="bib0390" /><span class="label" tagx="label" title="label">37</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Xiang</span><span class="given-names" tagx="given-names" title="given-names">P.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Xu</span><span class="given-names" tagx="given-names" title="given-names">X.M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Gao</span><span class="given-names" tagx="given-names" title="given-names">L.L.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wang</span><span class="given-names" tagx="given-names" title="given-names">H.Z.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Xiong</span><span class="given-names" tagx="given-names" title="given-names">H.F.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Li</span><span class="given-names" tagx="given-names" title="given-names">R.H.</span></span></span><span class="mixed-article-title" title="mixed-article-title">First Case of 2019 novel coronavirus disease with encephalitis</span><span class="source" tagx="source" title="source">ChinaXiv</span><span class="year" tagx="year" title="year">2020</span><span class="comment">T202003.00015</span></span></li> <li tag="ref"><a name="bib0395" /><span class="label" tagx="label" title="label">38</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Jacomy</span><span class="given-names" tagx="given-names" title="given-names">H.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Fragoso</span><span class="given-names" tagx="given-names" title="given-names">G.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Almazan</span><span class="given-names" tagx="given-names" title="given-names">G.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Mushynski</span><span class="given-names" tagx="given-names" title="given-names">W.E.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Talbot</span><span class="given-names" tagx="given-names" title="given-names">P.J.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Human coronavirus OC43 infection induces chronic encephalitis leading to disabilities in BALB/C mice</span><span class="source" tagx="source" title="source">Virology</span><span class="volume" tagx="volume" title="volume">349</span><span class="year" tagx="year" title="year">2006</span><span class="fpage" tagx="fpage" title="fpage">335</span><span class="lpage" tagx="lpage" title="lpage">346</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/16527322">16527322</a></span></span></li> <li tag="ref"><a name="bib0400" /><span class="label" tagx="label" title="label">39</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Miller</span><span class="given-names" tagx="given-names" title="given-names">K.D.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Schnell</span><span class="given-names" tagx="given-names" title="given-names">M.J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Rall</span><span class="given-names" tagx="given-names" title="given-names">G.F.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Keeping it in check: chronic viral infection and antiviral immunity in the brain</span><span class="source" tagx="source" title="source">Nat Rev Neurosci.</span><span class="volume" tagx="volume" title="volume">17</span><span class="year" tagx="year" title="year">2016</span><span class="fpage" tagx="fpage" title="fpage">766</span><span class="lpage" tagx="lpage" title="lpage">776</span><span class="pub-id"><a href="https://dx.doi.org/10.1038/nrn.2016.140">10.1038/nrn.2016.140</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/27811921">27811921</a></span></span></li> <li tag="ref"><a name="bib0405" /><span class="label" tagx="label" title="label">40</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lin</span><span class="given-names" tagx="given-names" title="given-names">L.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zheng</span><span class="given-names" tagx="given-names" title="given-names">L.J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhang</span><span class="given-names" tagx="given-names" title="given-names">L.J.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Neuroinflammation, gut microbiome, and Alzheimer's Disease</span><span class="source" tagx="source" title="source">Mol Neurobiol.</span><span class="volume" tagx="volume" title="volume">55</span><span class="year" tagx="year" title="year">2018</span><span class="fpage" tagx="fpage" title="fpage">8243</span><span class="lpage" tagx="lpage" title="lpage">8250</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/29524051">29524051</a></span></span></li> <li tag="ref"><a name="bib0410" /><span class="label" tagx="label" title="label">41</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">MatÃ­as-Guiu</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Gomez-Pinedo</span><span class="given-names" tagx="given-names" title="given-names">U.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Montero-Escribano</span><span class="given-names" tagx="given-names" title="given-names">P.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Gomez-Iglesias</span><span class="given-names" tagx="given-names" title="given-names">P.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Porta-Etessam</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Matias-Guiu</span><span class="given-names" tagx="given-names" title="given-names">J</span></span></span><span class="mixed-article-title" title="mixed-article-title">Â¿Es esperable que haya cuadros neurolÃ³gicos por la pandemia de SARS2-CoV?</span><span class="source" tagx="source" title="source">Neurologia</span><span class="year" tagx="year" title="year">2020</span><span class="pub-id"><a href="https://dx.doi.org/10.1016/j.nrl.2020.03.001">10.1016/j.nrl.2020.03.001</a></span><span class="comment">Online first.</span></span></li> </ul> </div> <div class="anexo" title="sec"><span class="label" tagx="label" title="label">Appendix A</span><div class="title" tagx="title" title="title">
Anexo</div> <p id="par0240">Neuro-RECA es una Red de investigaciÃ³n clÃ­nica y traslacional en NeurologÃ­a financiada por la LÃ­nea de Proyectos de InvestigaciÃ³n, Desarrollo e InnovaciÃ³n BiomÃ©dica y en Ciencias de la Salud (modalidad proyectos de investigaciÃ³n clÃ­nica en red) de la SecretarÃ­a General de InvestigaciÃ³n, Desarrollo e InnovaciÃ³n en Salud de la Consejeria de Salud y Familias de la Junta de AndalucÃ­a (Expte RIC-0111-2019). EstÃ¡ integrada por mÃ¡s de 90 investigadores pertenecientes a 18 centros asistenciales y de investigaciÃ³n clÃ­nica en NeurologÃ­a y grupos de investigaciÃ³n preclÃ­nica en Neurociencias en AndalucÃ­a. Cuenta con la colaboraciÃ³n del Centro de BiologÃ­a Molecular y Medicina Regenerativa (CABIMER), de la Red Andaluza de DiseÃ±o y TraslaciÃ³n de Terapias Avanzadas y de las Sociedades cientÃ­ficas de AtenciÃ³n primaria SEMFyC y SEMERGEN.</p> </div> </div>  </body></html>